Meros Investment Management LP acquired a new position in Simulations Plus, Inc. (NASDAQ:SLP – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 130,229 shares of the technology company’s stock, valued at approximately $2,384,493. Meros Investment Management LP owned approximately 0.64% of Simulations Plus at the end of the most recent reporting period.
Other institutional investors and hedge funds have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after purchasing an additional 390 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Simulations Plus by 26.0% during the second quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock worth $52,000 after purchasing an additional 585 shares during the period. Bank of New York Mellon Corp lifted its stake in Simulations Plus by 1.3% in the first quarter. Bank of New York Mellon Corp now owns 63,592 shares of the technology company’s stock valued at $752,000 after purchasing an additional 844 shares during the last quarter. Deutsche Bank AG raised its position in shares of Simulations Plus by 5.9% during the 4th quarter. Deutsche Bank AG now owns 15,825 shares of the technology company’s stock valued at $288,000 after buying an additional 875 shares in the last quarter. Finally, Prudential Financial Inc. raised its holdings in shares of Simulations Plus by 5.7% during the second quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock valued at $300,000 after acquiring an additional 930 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.
Insider Buying and Selling
In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the transaction, the director directly owned 3,202,131 shares in the company, valued at approximately $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 19.10% of the stock is currently owned by company insiders.
Simulations Plus Stock Down 0.1%
Simulations Plus (NASDAQ:SLP – Get Free Report) last issued its earnings results on Thursday, July 9th. The technology company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.23 by $0.07. Simulations Plus had a return on equity of 13.50% and a net margin of 9.88%.The business had revenue of $21.89 million for the quarter, compared to the consensus estimate of $20.90 million.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on SLP shares. Wall Street Zen downgraded shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Weiss Ratings upgraded Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a report on Thursday, June 18th. Finally, William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Seven investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Reduce” and a consensus target price of $17.25.
View Our Latest Analysis on Simulations Plus
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Read More
- Five stocks we like better than Simulations Plus
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
